Skip to main navigation Skip to search Skip to main content

A DOUBLE BLIND RANDOMIZED CONTROLLED STUDY TO EVALUATE THE IMMUNOGENICITY AND SAFETY OF GLAXOSMITHKLINE BIOLOGICALS' HERPES SIMPLEX CANDIDATE VACCINE IN HEALTHY HSV SERONEGATIVE AND SEROPOSITIVE FEMALE SUBJECTS

Project: Research

Project Details

StatusFinished
Effective start/end date06/24/04 → 02/7/08

Funding

  • GlaxoSmithKline: $22,512.00